North America is home to the most expensive and least expensive Celebrex, according to the International Federation of Health Plans’ 2013 Comparative Price Report.
The average price for a 1-month supply of Celebrex (celecoxib) was $225 in the United States last year, compared with $51 in Canada, the IFHP reported. The other countries in the survey were the Netherlands ($112), England ($112), Switzerland ($138), and Spain ($164).
Celebrex is approved in the United States for the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis in patients 2 years and older, ankylosing spondylitis, acute pain, and primary dysmenorrhea.
The IFHP comprises more than 100 member companies in 25 countries. For the survey, the price for each country was submitted by participating member plans. Some prices are drawn from the public sector, some from the private, and some from both. U.S. averages were calculated from more than 100 million claims in the Truven MarketScan Research databases.
